Table III.
Means, standard deviations and polychoric correlations for all age groups for items representing understanding and appreciation.
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Adherence | ||||||||||||||
Purpose | .30*** | |||||||||||||
Safety Screening | .46*** | .29*** | ||||||||||||
Phases | .53*** | .10 | .32*** | |||||||||||
Medical Procedures | .43*** | .15* | .08 | .43*** | ||||||||||
Side effects | .58*** | .26*** | .30*** | .41*** | .46*** | |||||||||
Benefits | .24*** | .03 | .15* | .29*** | .28*** | .04 | ||||||||
Inclusion criteria | .51*** | .26*** | .40*** | .41*** | .18** | .51*** | .17** | |||||||
Responsibilities | .14* | .18** | .36*** | .22** | .34*** | .24*** | .40*** | .31*** | ||||||
Research-Treatment | .36*** | .22** | .30*** | .41*** | .37*** | .37*** | .22*** | .55*** | .25*** | |||||
HIV+ | .25*** | .27*** | .40*** | .19** | .08 | .36*** | .23*** | .47*** | .46*** | .60*** | ||||
Confidentiality | .19** | .15* | .28*** | .35*** | .31*** | .30*** | .13 | .31*** | .49*** | .40*** | .41*** | |||
Randomization | .32*** | −.06 | −.04 | .54*** | .39*** | .31*** | .46*** | .47*** | .26*** | .67*** | .36*** | .49*** | ||
Voluntarism | .39*** | .08 | .19** | .37*** | .20** | .30*** | .33*** | .42*** | .38*** | .44*** | .44*** | .24*** | .24*** | |
Mean | 1.80 | 1.59 | 1.45 | 1.83 | 1.79 | 1.80 | 1.64 | 1.39 | 1.85 | 1.79 | 1.79 | 1.89 | 1.92 | 1.76 |
SD | .55 | .63 | .60 | .48 | .52 | .46 | .67 | .78 | .44 | .55 | .55 | .34 | .38 | .43 |
p < .05
p < .01
p < .001